Pear Therapeutics Inc
NASDAQ:PEAR
Pear Therapeutics Inc
Income from Continuing Operations
Pear Therapeutics Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Pear Therapeutics Inc
NASDAQ:PEAR
|
Income from Continuing Operations
-$75.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Veeva Systems Inc
NYSE:VEEV
|
Income from Continuing Operations
$525.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
36%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Income from Continuing Operations
-$15.7m
|
CAGR 3-Years
35%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Income from Continuing Operations
-$110.3m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Income from Continuing Operations
$147.6m
|
CAGR 3-Years
43%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Income from Continuing Operations
-$8.9m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pear Therapeutics Inc's Income from Continuing Operations?
Income from Continuing Operations
-75.5m
USD
Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Income from Continuing Operations amounts to -75.5m USD.
What is Pear Therapeutics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-16%
Over the last year, the Income from Continuing Operations growth was -16%.